Tristan T. Sands, MD, PHD

Call
Website

Photos

180 Fort Washington Ave
New York, NY 10032
+1 (646) 426-3876
https://doctors.columbia.edu
Tristan T. Sands, MD, PhD is Assistant Professor in the Columbia University Vagelos College of Physicians & Surgeons (Columbia VP&S) Departments of Neurology and Pediatrics. He is a pediatric neurologist who treats children and babies suffering from epilepsy and a physician scientist with expertise in genetic causes of epilepsy and neurodevelopmental disease. Dr. Sands completed his MD-PhD at Columbia VP&S through a Medical Scientist Training Program with thesis work in lab of Dr. Arnold Kriegstein. During child neurology residency at UCSF, Dr. Sands trained in electroclinical phenotyping of the epilepsies under Dr. M. Roberta Cilio. After finishing his clinical training at Columbia VP&S in epilepsy and clinical neurophysiology with Dr. Jim Riviello, Dr. Sands joined Columbia VP&S as faculty in 2017, first training in neurogenetics at the Institute for Genomic Medicine, and then returning to the bench to study genetic epilepsy using mouse models under the mentorship of Dr. Wayne Frankel. Dr. Sands has worked closely with families to treat hundreds of children with epilepsy. He is the author of chapters on pediatric epilepsy and genetic epilepsy in major textbooks in the field of neurology, including Merritt’s Neurology and Swaiman’s Pediatric Neurology. Dr. Sands has served as an expert on ClinGen’s epilepsy gene curation panel since 2017. In 2023, Dr. Sands was named Fellow of the American Epilepsy Society in recognition of professional accomplishment and dedication in the field of epilepsy. Dr. Sands is a 2024 Louis V. Gerstner Scholar. His research contributions include demonstration of the exquisite efficacy of carbamazepine for neonatal epilepsy caused by inherited loss-of-function variants in KCNQ2 and KCNQ3, work that led to changes to the International League against Epilepsy guidelines and recommendations on the treatment of seizures in newborn babies. Dr. Sands reported the electroclinical characterization of a new gain-of-function phenotype caused by de novo variants in KCNQ3. Dr. Sands reported variants in NBEA as a cause epilepsy and neurodevelopment, and he characterized the largest cohort of patients with epilepsy and neurodevelopmental disability caused by pathogenic variants in CSNK2B. The Sands "END (Epilepsy & Neurodevelopmental Disease) Laboratory," established in 2022 in the Center for Translational Research in Neurodevelopmental Disease (CTRND), uses mouse and human cellular models to identify convergent disease mechanisms and novel therapeutic strategies for epilepsy and encephalopathy caused by rare genetic mutations. These research efforts are supported by federal grants from both NIH and private agencies.
Click or call for more information

Also at this address

Owner verified
See a problem?

You might also like

Min Shen, MD
Internal medicine practitioners

Min Shen, MD

Min Ye Shen, MD is an assistant professor of neurology at Columbia University Irving Medical Center in the Division of Child Neurology. Dr. Shen received her undergraduate degree from Columbia University School of Engineering and Applied Science and her medical degree from Weill Cornell Medical College. She completed her residency in child neurology and fellowship in clinical neurophysiology, with a focus on electroencephalograms (EEG) at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Shen is a pediatric neurologist and epileptologist with clinical focuses on inpatient pediatric neurology and acute neurological conditions, as well as general outpatient pediatric neurology, seizures, and neonatal and pediatric epilepsy.
Jennifer Jones, AUD
Internal medicine practitioners

Jennifer Jones, AUD

Jennifer Bain, MD, PhD, is an Associate Professor of Neurology and Pediatrics at the Columbia University Medical Center. Dr. Bain completed both an MD and PhD, as well as general pediatrics residency at Rutgers – New Jersey Medical School in New Jersey. She then trained in Child Neurology at NewYork-Presbyterian/Columbia University Irving Medical Center in New York City and is a board-certified neurologist with special certification in Child Neurology seeing both inpatient and outpatient pediatric neurology patients. Her clinic focuses on diagnosis and management of autism, cerebral palsy and neurodevelopmental disorders in addition to genetic disorders associated with such conditions. Her early research career focused on spinal cord and brain development after injuries such as spinal cord injury and perinatal hypoxic ischemic encephalopathy. During her residency training, her clinical research focused on studying autonomic dysfunction in children with autism spectrum disorders and neurological complications during extracorporeal membrane oxygenation. She currently works as a physician scientist at Columbia University specializing in general pediatric neurology with expertise in development, behavioral neurology, autism and cerebral palsy. Her clinical research has focused on studying the genetics of neurodevelopmental disorders including autism and cerebral palsy. The genes she has worked closely on include HNRNPH2 and related disorders, GRIN disorders, KIF1A. She is interested in understanding clinically meaningful measures in families affected by neurodevelopmental disorders and measuring longitudinal trajectories in such disorders. She has been working closely with several patient advocacy groups, researchers, and Simons Searchlight to continuously move forward in the understanding of the developing and aging brain.
Gurcharanjeet Kaur, MD
Internal medicine practitioners

Gurcharanjeet Kaur, MD

Gurcharanjeet Kaur, MD is an assistant professor of neurology at CUIMC, in the Division of Child Neurology. Dr. Kaur is a graduate of Lady Hardinge Medical College in New Delhi, India. She completed residency in both pediatric neurology and neuro-oncology at Stony Brook University Medical Center and Memorial Sloan Kettering Cancer Center, respectively. Dr. Kaur is a board-certified child neurologist and pediatric neuro-oncologist, with particular expertise in neurofibromatosis (NF) and NF-related tumors, cancer related neurotoxicity, and tumor targeted therapy for low grade gliomas. Dr. Kaur is dedicated to helping children while minimizing the toxicities and residual deficits by providing the highest quality of care and access to recent advances in the field. Dr. Kaur remains committed to clinical and pre-clinical research. She has been involved in the clinical trials as a site principal investigator and co-investigator. She mentors’ residents, fellows, and medical students interested in the field of child neurology and neuro-oncology.
United States›New York›New York›Tristan T. Sands, MD, PHD

Yext

Partial Data by Foursquare.